Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05500508
Title	Oral AMXT 1501 Dicaprate in Combination With IV DFMO
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Aminex Therapeutics, Inc.
Indications	esophageal cancer malignant pleural mesothelioma diffuse midline glioma, H3 K27M-mutant breast cancer fallopian tube cancer ovarian cancer melanoma papillary thyroid carcinoma peritoneal mesothelioma peritoneum cancer high grade glioma head and neck cancer colorectal cancer cervical cancer endometrial cancer lung non-small cell carcinoma stomach cancer
Therapies	AMXT1501 + Eflornithine
Age Groups:	senior \| adult \| child
Covered Countries	USA \| AUS